Journal
FRONTIERS IN ONCOLOGY
Volume 11, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2021.731561
Keywords
therapy resistance; cancer stem-like cells; tyrosine kinase inhibitor; n6-methyladenosine; miRNAs maturation
Categories
Funding
- National Science Foundation for Young Scientists of China [81602597, 82003140]
- Foundation Research Project of Shaanxi Province [2021SF-117]
- The Natural Science Basic Research Program of Shaanxi [2018JM7017]
Ask authors/readers for more resources
This study identified a novel strategy to enhance the effectiveness of tyrosine kinase inhibitor (TKIs) therapy by activating Let-7b expression and reducing the stem cell population. They revealed the involvement of METTL3 and DNMT3a/b in the regulation of Let-7b and discovered that the maturation processing signaling can influence the methylation control of miRNAs.
The molecular mechanism of the tyrosine kinase inhibitor (TKI) resistant lung adenocarcinoma is currently unclear, and the role of methylated adenosine at the N6 position in the resistance of cancer stem cells (CSCs) therapy is unknown. This study identified a novel and effective strategy to enhance TKIs therapy response. We first confirmed the sensitization of Metformin enforcing on Osimertinib treatment and revealed the mature miRNAs signatures of the Osimertinib resistant H1975 and HCC827 cells. Let-7b expression was stimulated when adding Metformin and then increasing the therapy sensitivity by decreasing the stem cell groups expanding. Methyltransferase-like 3 (METTL3) increased the pri-Let-7b, decreased both the pre-Let-7b and mature Let-7b, attenuating the Let-7b controlling of stem cell renewal. The addition of Metformin increased the bindings of DNA methyltransferase-3a/b (DNMT3a/b) to the METTL3 promoter. With the help of the readers of NKAP and HNRNPA2B1, the cluster mediated m6A formation on pri-Let-7b processing increased the mature Let-7b, the key player in suppressing Notch signaling and re-captivating Osimertinib treatment. We revealed that the maturation processing signaling stimulated the methylation regulation of the miRNAs, and may determine the stemness control of the therapy resistance. Our findings may open up future drug development, targeting this pathway for lung cancer patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available